CICC: Maintain Minimally Invasive Medical (00853) "outperform industry" rating and raise target price to HK$17.
Wisdom Finance APP learned that CICC released a research report stating that it maintains its profit forecast for Microport Medical (00853) in 2025/26. The bank maintains its outperform rating. Based on the improved shareholder structure of the company, the optimism for the launch of new products in the domestic market and the acceleration of overseas business, as well as the overall recovery of the healthcare sector in the Hong Kong stock market, the bank has raised its target price based on the DCF model (WACC 8.9%, perpetual growth rate 1.9%) by 54.5% to HK$17, representing a 31% upside potential from the current price.
Latest